Sanofi’s consumer unit draws offers from Advent, PAI, Bloomberg reports
PremiumThe FlySanofi’s consumer unit draws offers from Advent, PAI, Bloomberg reports
8d ago
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe Fly
Jefferies healthcare analyst holds an analyst/industry conference call
13d ago
Sanofi price target raised to EUR 125 from EUR 118 at Guggenheim
PremiumThe Fly
Sanofi price target raised to EUR 125 from EUR 118 at Guggenheim
14d ago
Kymera expands HS and AD Phase 2  trials following review
PremiumThe FlyKymera expands HS and AD Phase 2 trials following review
17d ago
Sanofi price target raised to EUR 111 from EUR 109 at Stifel
PremiumThe Fly
Sanofi price target raised to EUR 111 from EUR 109 at Stifel
17d ago
PE firms weigh possible bids for Sanofi consumer unit, Bloomberg says
PremiumThe Fly
PE firms weigh possible bids for Sanofi consumer unit, Bloomberg says
22d ago
Sanofi says frexalimab reduced biomarker of nerve cell damage in Phase 2 data
PremiumThe FlySanofi says frexalimab reduced biomarker of nerve cell damage in Phase 2 data
24d ago
Sanofi: Fexalimab Ph2 data showed lower key biomarker of nerve cell damage
PremiumThe Fly
Sanofi: Fexalimab Ph2 data showed lower key biomarker of nerve cell damage
27d ago
Sanofi investing $400M in Vigil Neuroscience, says Guggenheim
PremiumThe Fly
Sanofi investing $400M in Vigil Neuroscience, says Guggenheim
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100